Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP568035.RASiEqIu6E5Hmj_cShcFEaOYE-E_KjBdAaW5I1CjHzG_E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP568035.RASiEqIu6E5Hmj_cShcFEaOYE-E_KjBdAaW5I1CjHzG_E130_assertion type Assertion NP568035.RASiEqIu6E5Hmj_cShcFEaOYE-E_KjBdAaW5I1CjHzG_E130_head.
- NP568035.RASiEqIu6E5Hmj_cShcFEaOYE-E_KjBdAaW5I1CjHzG_E130_assertion description "[We fabricated custom 188-gene microarrays containing expression signatures for three breast cancer molecular subtypes [luminal/estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2), and 'basaloid'], the Nottingham prognostic index (NPI-ES), and low histologic grade (TuM1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP568035.RASiEqIu6E5Hmj_cShcFEaOYE-E_KjBdAaW5I1CjHzG_E130_provenance.
- NP568035.RASiEqIu6E5Hmj_cShcFEaOYE-E_KjBdAaW5I1CjHzG_E130_assertion evidence source_evidence_literature NP568035.RASiEqIu6E5Hmj_cShcFEaOYE-E_KjBdAaW5I1CjHzG_E130_provenance.
- NP568035.RASiEqIu6E5Hmj_cShcFEaOYE-E_KjBdAaW5I1CjHzG_E130_assertion SIO_000772 18223220 NP568035.RASiEqIu6E5Hmj_cShcFEaOYE-E_KjBdAaW5I1CjHzG_E130_provenance.
- NP568035.RASiEqIu6E5Hmj_cShcFEaOYE-E_KjBdAaW5I1CjHzG_E130_assertion wasDerivedFrom befree-20150227 NP568035.RASiEqIu6E5Hmj_cShcFEaOYE-E_KjBdAaW5I1CjHzG_E130_provenance.
- NP568035.RASiEqIu6E5Hmj_cShcFEaOYE-E_KjBdAaW5I1CjHzG_E130_assertion wasGeneratedBy ECO_0000203 NP568035.RASiEqIu6E5Hmj_cShcFEaOYE-E_KjBdAaW5I1CjHzG_E130_provenance.